收费全文 | 79681篇 |
免费 | 6095篇 |
国内免费 | 309篇 |
耳鼻咽喉 | 1229篇 |
儿科学 | 1860篇 |
妇产科学 | 1294篇 |
基础医学 | 9777篇 |
口腔科学 | 1579篇 |
临床医学 | 8320篇 |
内科学 | 16435篇 |
皮肤病学 | 931篇 |
神经病学 | 7019篇 |
特种医学 | 2929篇 |
外国民族医学 | 2篇 |
外科学 | 13745篇 |
综合类 | 1451篇 |
现状与发展 | 1篇 |
一般理论 | 56篇 |
预防医学 | 6318篇 |
眼科学 | 1833篇 |
药学 | 5732篇 |
8篇 | |
中国医学 | 154篇 |
肿瘤学 | 5412篇 |
2023年 | 459篇 |
2022年 | 671篇 |
2021年 | 1818篇 |
2020年 | 994篇 |
2019年 | 1758篇 |
2018年 | 2054篇 |
2017年 | 1547篇 |
2016年 | 1561篇 |
2015年 | 1847篇 |
2014年 | 2824篇 |
2013年 | 3752篇 |
2012年 | 5709篇 |
2011年 | 5978篇 |
2010年 | 3297篇 |
2009年 | 2899篇 |
2008年 | 5086篇 |
2007年 | 5530篇 |
2006年 | 5491篇 |
2005年 | 5349篇 |
2004年 | 4830篇 |
2003年 | 4847篇 |
2002年 | 4401篇 |
2001年 | 723篇 |
2000年 | 608篇 |
1999年 | 784篇 |
1998年 | 978篇 |
1997年 | 717篇 |
1996年 | 651篇 |
1995年 | 588篇 |
1994年 | 513篇 |
1993年 | 439篇 |
1992年 | 455篇 |
1991年 | 407篇 |
1990年 | 392篇 |
1989年 | 382篇 |
1988年 | 353篇 |
1987年 | 317篇 |
1986年 | 304篇 |
1985年 | 323篇 |
1984年 | 372篇 |
1983年 | 317篇 |
1982年 | 376篇 |
1981年 | 341篇 |
1980年 | 312篇 |
1979年 | 219篇 |
1978年 | 238篇 |
1977年 | 198篇 |
1976年 | 158篇 |
1975年 | 154篇 |
1974年 | 160篇 |
Areas covered: In this article, the authors describe the key features of RAGE and how it could have a role in AD pathogenesis. They also summarize experimental animal and clinical data that demonstrate the therapeutic effect of RAGE inhibition and consider what these findings mean for human disease.
Expert opinion: RAGE has multiple ligands, including Aβ, that are increased in AD brains. Inhibiting RAGE-ligand interactions without activating receptor signaling can reduce multiple pathological pathways relevant for AD. Several RAGE inhibitors and modulators are now being tested as therapeutics for AD. Recent Phase II studies have established the good safety and tolerability of TTP448 with some evidence of positive benefit at lower dose. This suggests that further studies are required. 相似文献
Duodenal aspiration (DA) and lactulose breath tests (LBT) are commonly performed to diagnose small intestinal bacterial overgrowth (SIBO). There are no data directly comparing these tests.
AimsTo investigate the agreement between DA and LBT for the diagnosis of SIBO.
MethodsA retrospective cohort study of adult patients who underwent a LBT and a DA at a tertiary care center over 9 years was assembled. LBT was considered positive if the hydrogen baseline or peak change measurement was ≥?20 ppm, and/or if the methane baseline or peak change was ≥?10 ppm. DA was considered positive if >?100,000 cfu/mL of gram-negative flora was identified on culture, and contaminated if >?100,000 cfu/mL of gram-positive flora was identified.
ResultsA total of 106 patients were evaluated; 81 (76.4%) were female; the mean age was 53.4?±?15.9 years. 21 patients (19.8%) had evidence of contamination on DA. 14 (16.5%) patients had a positive DA result. Patients with diabetes mellitus and those with PPI use were more likely to have a positive DA (94.4% vs. 71.4%, p?=?0.007; 62% vs. 28.6%, p?=?0.021, respectively). 33 (31.1%) patients had a positive LBT. Patients with a history of small bowel resection were more likely to have a positive LBT (12.1% vs. 1.4%, p?=?0.016). DA and LBT results agreed in 54 patients (63.5%; kappa?=???0.02), indicating poor agreement.
ConclusionsThe agreement between LBT and DA in evaluation for SIBO was poor. LBT may be favorable to DA, as LBT is safer, cheaper, and less likely to yield a contaminant result.
相似文献